Stenotrophomonas maltophilia bloodstream infections in children 35 36 ABSTRACT 37 Treatment of invasive infections caused by Stenotothromhomas maltophilia is difficult as the 38 bacterium is frequently resistant to a wide range of commonly used antimicrobials. The aim of 39 this retrospective study was to evaluate effectiveness of treatment with ciprofloxacin 40 monotherapy compared to trimethoprim-sulfamethoxazole monotherapy in patients with S. 41 maltophilia infections. We evaluated 50 patients with S. maltophilia bloodstream infections 42 who had received monotherapy with trimethoprim-sulfamethoxazole or ciprofloxacin. 43 Twenty-five patients (50%) received trimethoprim-sulfamethoxazole, and 25 patients (50%) 44 received ciprofloxacin. Thirty-six (72%) patients were in the intensive care unit. All of the 45 patients had at least one indwelling devices and approximately 25% patients had 46 immunosuppression. Ciprofloxacin had the same clinical outcome and mortality as 47 trimethoprim-sulfamethoxazole for the treatment of S. maltophilia bacteremia. In our study; 48 side-effects ratio were not statistically different between ciprofloxacin and trimethoprim-49 sulfamethoxazole group. Ciprofloxacin could be an alternative drug of choice for treating S. 50 maltophilia infections especially in premature infans in stead of trimethoprim-51 sulfamethoxazole.
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